Initial Psychiatric Visit for Alzheimer's Disease with Reduced Cognitive Capacity
The initial psychiatric encounter for an Alzheimer's patient must systematically characterize neuropsychiatric symptoms (NPS), investigate underlying modifiable causes across patient/caregiver/environmental domains, and establish baseline cognitive, functional, and behavioral assessments to guide treatment. 1
Core Assessment Framework
Step 1: DESCRIBE the Neuropsychiatric Symptoms
The first critical task is moving beyond vague descriptors to precise symptom characterization 1:
- Probe specific behaviors: When caregivers use terms like "agitation" or "confusion," determine exactly what they mean—is it physical aggression, verbal outbursts, wandering, repetitive questions, or anxiety?
- Elicit the patient's perspective: Even with moderate dementia, ask what the patient can describe about their symptoms and what distresses them most
- Identify caregiver goals and understanding: Determine if the caregiver understands that NPS stem from dementia rather than intentional behavior ("doing this on purpose")
- Document temporal patterns: Use diaries or logs to track when symptoms occur, their triggers, and duration
Common presenting symptoms to assess 2:
- Memory loss (76% of cases)
- Difficulty performing familiar tasks (76.7%)
- Misplacing items (72.7%)
- Language difficulties
- Disorientation to time/place
- Poor judgment
- Personality changes
Step 2: INVESTIGATE Underlying Causes
This parallels delirium workup—NPS often have modifiable medical triggers 1:
Patient-Level Factors
Medical conditions to rule out:
- Urinary tract infections (patients with dementia suffer disproportionately from undiagnosed infections)
- Pain (often unrecognized and undertreated)
- Constipation
- Dehydration
- Anemia
- Electrolyte abnormalities
Medication review 1:
- Have caregiver bring ALL bottles (prescription, OTC, supplements)
- Identify anticholinergic medications that worsen cognition
- Assess for drug-drug interactions
- Review for medications causing behavioral side effects
Other patient factors:
- Prior psychiatric history (lifelong depression/anxiety)
- Sleep hygiene and sleep disorders
- Sensory impairments (vision, hearing)
- Functional limitations and boredom
- Psychological distress (feeling like "a burden")
Caregiver-Level Factors 1
- Relationship quality: Historical and current dynamics between patient and caregiver
- Communication style: Does the caregiver speak too fast, give complex instructions, or become confrontational?
- Expectations: Are they over- or underestimating the patient's abilities?
- Caregiver stress/depression: Nearly half of caregivers become depressed 3—their mental health directly impacts patient symptoms
- Cultural context: Beliefs about nursing home placement, discussing symptoms with "outsiders," family obligations
Environmental Factors 1
- Over- or under-stimulation in the home
- Way-finding challenges (can patient navigate safely?)
- Lack of predictable routines
- Absence of pleasurable activities
- Safety concerns: Can patient leave home unsupervised? Access to dangerous objects (knives, guns)?
Cognitive and Functional Assessment
Cognitive Testing 2, 4
- Mini-Mental State Examination (MMSE): Mean score in suspected AD is approximately 19.9 ± 5.2 (mild AD range)
- Additional neuropsychological tests as needed:
- Token Test
- Verbal fluency for semantic categories
- Prose memory test
- Judgment of line orientation
- Raven test
Functional Assessment 1, 5
- Activities of Daily Living (ADL) scales
- Instrumental Activities of Daily Living (IADL)
- Blessed Dementia Scale (BDS): Particularly important as depressive symptoms correlate significantly with deterioration in daily living activities (r = 0.85, p = 0.0004) 5
Behavioral Assessment 1, 5
- Hamilton Rating Scale for Depression (HRS-D): Depression is a major component at disease onset
- Non-cognitive session of ADAS (Alzheimer's Disease Assessment Scale)
- Screen for:
- Depressive mood
- Auto- and hetero-aggressive behavior
- Psychomotor agitation
- Anxiety disorders
- Sleep disorders
- Delusions and hallucinations (30% prevalence at onset) 5
Physical and Laboratory Workup
Neurological Examination 2
- Assess for walk apraxia (10.8% of cases)
- Extrapyramidal signs (10.7%)
- General neurological status
Laboratory Testing 2, 4
Essential blood work (ordered in 90% of cases):
- Complete blood count with differential
- Comprehensive metabolic panel (glucose, electrolytes)
- Urinalysis
- Consider thyroid function, B12 levels
Neuroimaging 2
- CT scan: Used in 66.8% of initial evaluations
- Consider MRI for more detailed assessment if available
Diagnostic Formulation
Establish diagnosis using standardized criteria 3, 6:
- Spanish Society of Neurology criteria (69.5% diagnosed with AD in specialist settings) 2
- Current biological staging incorporates Core 1 biomarkers (amyloid PET, CSF biomarkers, plasma phosphorylated tau-217) when available 6
- Diagnosis is primarily one of inclusion, not exclusion 3
Treatment Planning Discussion
Pharmacologic Options 7, 8
For cognitive symptoms:
- Cholinesterase inhibitors (87.8% of patients receive these as principal treatment) 2:
- Donepezil: Most commonly prescribed, once-daily dosing, well-tolerated, but requires cardiac monitoring
- Rivastigmine: Twice-daily or transdermal patch, fewer cardiac effects
- Galantamine: Delays BPSD development, minimal drug interactions
- Memantine: For moderate-to-severe disease, glutamate regulation
For behavioral symptoms 7:
- Brexpiprazole: For agitation (once-daily atypical antipsychotic)
- Suvorexant: For sleep disturbances (orexin receptor antagonist)
Non-pharmacologic Interventions 8
- Cognitive stimulation
- Physical exercise programs
- Dietary modifications
- Social inclusion activities
- Sleep hygiene optimization
Follow-up Planning
Schedule return visit 2:
- Mean time: 4 months (± 2.4 months)
- 95.5% see the same physician for continuity
Critical Pitfalls to Avoid
Don't accept vague symptom descriptions: "Agitation" could mean 10 different things—get specifics 1
Don't assume intentionality: Educate caregivers that behaviors stem from brain disease, not willful actions 1
Don't miss treatable medical causes: UTIs, pain, and medication effects are frequently overlooked 1
Don't ignore caregiver mental health: Their depression and stress directly worsen patient symptoms 1, 3
Don't delay diagnosis: Patients often wait 1-3 years after symptom onset before seeking help 2—early intervention improves outcomes
Don't overlook safety: Assess home safety, wandering risk, and access to dangerous items systematically 1